Projects

Development and validation of a deprescribing tool relevant to the Indian context and evaluation of its effectiveness in reducing inappropriate polypharmacy in the elderly (ICMR-SRUM-NTF)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2023 - Ongoing

Project Lead

Dr. Atiya R Faruqui

Authors

PI: Dr. Atiya R. Faruqui, Co-I: Dr. Geetha Francis, Dr. Pretesh Kiran

Project Status

ongoing